$CWBR
CohBar Inc Stock $cwbr

$cwbr Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023018882 Filed on March 09, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.279M	$1.717M	$6.553M
YoY Change	-26.69%	-13.41%	-14.94%
% of Gross Profit
Research & Development	$1.021M	$2.205M	$5.936M
YoY Change	-32.24%	176.17%	-22.96%
% of Gross Profit
Depreciation & Amortization	$63.48K	$12.49K	$99.25K
YoY Change	93.54%	-62.35%	-29.56%
% of Gross Profit
Operating Expenses	$2.300M	$3.923M	$12.39M
YoY Change	-29.26%	41.02%	-19.6%
Operating Profit	-$2.300M		-$12.39M
YoY Change	-29.26%		-19.6%
Interest Expense	$134.2K	$126.0K	$213.1K
YoY Change	-1371.66%	-1276.66%	-415.13%
% of Operating Profit
Other Income/Expense, Net	$134.2K		$213.1K
YoY Change	-1372.03%		-415.12%
Pretax Income	-$2.166M	-$3.797M	-$12.18M
YoY Change	-33.6%	35.96%	-21.33%
Income Tax
% Of Pretax Income
Net Earnings	-$2.166M	-$3.797M	-$12.18M
YoY Change	-33.6%	35.96%	-21.33%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.75		-$4.20
Diluted Earnings Per Share	-$0.75	-$1.30	-$4.20
COMMON SHARES
Basic Shares Outstanding	2.907M shares	2.907M shares	2.900M shares
Diluted Shares Outstanding	2.907M shares		2.900M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.08M	$15.74M	$15.74M
YoY Change	-40.15%	-40.04%	-40.04%
Cash & Equivalents	$5.392M	$5.931M	$5.931M
Short-Term Investments	$8.689M	$9.807M	$9.807M
Other Short-Term Assets	$237.3K	$453.7K	$453.7K
YoY Change	-36.78%	-13.97%	-13.97%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$14.32M	$16.22M	$16.22M
YoY Change	-40.1%	-39.81%	-39.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.335K	$65.51K	$65.51K
YoY Change	-98.98%	-74.86%	-74.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$63.57K	$63.57K	$63.57K
YoY Change	-17.01%	-8.69%	-8.69%
Total Long-Term Assets	$83.68K	$147.2K	$147.2K
YoY Change	-74.15%	-57.9%	-57.9%
TOTAL ASSETS
Total Short-Term Assets	$14.32M	$16.22M	$16.22M
Total Long-Term Assets	$83.68K	$147.2K	$147.2K
Total Assets	$14.40M	$16.37M	$16.37M
YoY Change	-40.55%	-40.04%	-40.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$532.4K	$180.1K	$180.1K
YoY Change	-16.9%	-51.58%	-51.58%
Accrued Expenses	$49.51K	$327.9K	$853.5K
YoY Change	-91.51%	67.26%	-10.19%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00		$0.00
YoY Change
Long-Term Debt Due		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$898.5K	$1.034M	$1.034M
YoY Change	-26.58%	-38.79%	-38.79%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$898.5K	$1.034M	$1.034M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$898.5K	$1.034M	$1.034M
YoY Change	-26.58%	-38.79%	-38.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$99.08M	-$96.91M
YoY Change		14.37%
Common Stock	$2.907K	$2.907K
YoY Change		-96.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.50M	$15.33M	$15.33M
YoY Change
Total Liabilities & Shareholders Equity	$14.40M	$16.37M	$16.37M
YoY Change	-40.55%	-40.04%	-40.04%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$2.166M	-$3.797M	-$12.18M
YoY Change	-33.6%	35.96%	-21.33%
Depreciation, Depletion And Amortization	$63.48K	$12.49K	$99.25K
YoY Change	93.54%	-62.35%	-29.56%
Cash From Operating Activities	-$1.628M	-$2.727M	-$10.45M
YoY Change	-35.35%	0.49%	-27.69%
INVESTING ACTIVITIES
Capital Expenditures		$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$1.090M	$4.447M	$11.52M
YoY Change	-248.3%	-128.84%	-467.43%
Cash From Investing Activities	$1.090M	$4.447M	$11.52M
YoY Change	-248.3%	-128.84%	-466.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000	-$139.5K
YoY Change		-100.0%	-100.71%
NET CHANGE
Cash From Operating Activities	-$1.628M	-2.727M	-$10.45M
Cash From Investing Activities	$1.090M	4.447M	$11.52M
Cash From Financing Activities		0.000	-$139.5K
Net Change In Cash	-$538.3K	1.719M	$938.6K
YoY Change	-84.3%	-141.05%	-55.25%
FREE CASH FLOW
Cash From Operating Activities	-$1.628M	-$2.727M	-$10.45M
Capital Expenditures		$0.00
Free Cash Flow		-$2.727M	-$10.45M
YoY Change		0.49%	-27.66%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	327868	usd
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Cancelled Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelledDateFairValue
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38326
CY2022	dei	Entity Registrant Name EntityRegistrantName	COHBAR, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1299952
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1455 Adams Drive
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2050
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Menlo Park
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94025
CY2022	dei	City Area Code CityAreaCode	(650)
CY2022	dei	Local Phone Number LocalPhoneNumber	446-7888
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	CWBR
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	14064722	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2906926	shares
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum llp
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5930731	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4992145	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	9806591	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	21253866	usd
CY2022Q4	cwbr	Vendor Receivable VendorReceivable	27500	usd
CY2021Q4	cwbr	Vendor Receivable VendorReceivable	173499	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	453681	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	527380	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	16218503	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	26946890	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	65509	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	260612	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	18083	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	19309	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	63572	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	69620	usd
CY2022Q4	us-gaap	Assets Assets	16365667	usd
CY2021Q4	us-gaap	Assets Assets	27296431	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	180104	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	371993	usd
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelledd Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelleddContractualLifeYears
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledIntrinsicValue		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	196020	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	525666	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	754314	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	8723	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	366277	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1033638	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1688604	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2906926	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2906926	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2877985	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2877985	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2907	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2878	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	112238392	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	110339011	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-96909270	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84734062	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15332029	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	25607827	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16365667	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27296431	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5935718	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7705090	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6452579	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7703065	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	12388297	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	15408155	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-12388297	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-15408155	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	223291	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	5578	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	1479	usd
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	40108	usd
CY2022	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-8723	usd
CY2021	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-33091	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	213089	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-67621	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12175208	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-15475776	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.2
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.97
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2900202	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2220981	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	18487155	usd
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercised		shares
CY2022	cwbr	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercised ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercised
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Exercise ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceExercise
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2543712	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	16814	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	1240490	usd
CY2021	cwbr	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	2089476	usd
CY2021	cwbr	Sale Of Common Stock In Atm Net SaleOfCommonStockInATMNet	2884786	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	13821170	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-15475776	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	25607827	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1663911	usd
CY2022	cwbr	Sale Of Common Stock In Atm Net SaleOfCommonStockInATMNet	210542	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25025	usd
CY2022	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:30
CY2022	cwbr	Payout For Fractional Shares Retired As A Result Of Reverse Stock Split PayoutForFractionalSharesRetiredAsAResultOfReverseStockSplit	-68	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12175208	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15332029	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12175208	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-15475776	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	99247	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	140914	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	6449	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1663911	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2543712	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	8350	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	31687	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	373	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1405	usd
CY2022	cwbr	Discount On Investments DiscountOnInvestments	32275	usd
CY2021	cwbr	Discount On Investments DiscountOnInvestments	-1600	usd
CY2022	cwbr	Vendor Receviables VendorReceviables	-145999	usd
CY2021	cwbr	Vendor Receviables VendorReceviables	173499	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-73699	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	113688	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-191889	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-355606	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	131848	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-945721	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-228648	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-99021	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10446492	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14447193	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6397	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	103531	usd
CY2022	cwbr	Payment For Security Deposit PaymentForSecurityDeposit	-6048	usd
CY2021	cwbr	Payment For Security Deposit PaymentForSecurityDeposit	2217	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2359	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	56650000	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	43601000	usd
CY2022	cwbr	Proceeds From Redemptions Of Investments ProceedsFromRedemptionsOfInvestments	68065000	usd
CY2021	cwbr	Proceeds From Redemptions Of Investments ProceedsFromRedemptionsOfInvestments	40469000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	11524579	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3142973	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	25025	usd
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	16814	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	15000000	usd
CY2021	cwbr	Costs Of Public Offering CostsOfPublicOffering	-1178830	usd
CY2022	cwbr	Proceeds From The Atthe Market Offering Net ProceedsFromTheAttheMarketOfferingNet	216393	usd
CY2021	cwbr	Proceeds From The Atthe Market Offering Net ProceedsFromTheAttheMarketOfferingNet	2980595	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5851	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	95809	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2089476	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-375000	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-365000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1240490	usd
CY2022	cwbr	Reverse Stock Split Fractional Share Payout ReverseStockSplitFractionalSharePayout	-68	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-139501	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19687736	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	938586	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2097570	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4992145	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2894575	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5930731	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4992145	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	1332	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	1332	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	114411	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	89908	usd
CY2022Q4	us-gaap	Investments And Cash InvestmentsAndCash	15700000	usd
CY2022Q4	cwbr	Working Capital WorkingCapital	15200000	usd
CY2022	us-gaap	Stockholders Equity Other StockholdersEquityOther	15300000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12200000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3628689	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2600000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-variant: small-caps"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at dates of the financial statements and the reported amounts of revenue and expenses during the periods. Actual results could differ from these estimates. The Company’s significant estimates and assumptions include the fair value of financial instruments, stock-based compensation and the valuation allowance relating to the Company’s deferred tax assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><span style="font-variant: small-caps"><b><i> </i></b></span></p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-variant: small-caps"><b><i>Concentrations of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company maintains deposits in a financial institution which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-align: justify"><span style="font-variant: small-caps"><b><i> </i></b></span></p>
CY2022Q4	us-gaap	Us Government Securities At Carrying Value USGovernmentSecuritiesAtCarryingValue	9800000	usd
CY2021Q4	us-gaap	Us Government Securities At Carrying Value USGovernmentSecuritiesAtCarryingValue	21300000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	3900000	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	700000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3600000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4200000	usd
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercised Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisedDateFairValue
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1496026	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1554215	shares
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	419296	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	671883	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	65509	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	260612	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	6000	usd
CY2022Q4	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	100000	usd
CY2022	us-gaap	Selling Expense SellingExpense	100000	usd
CY2022	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	100000	usd
CY2021	us-gaap	Depreciation Expense On Reclassified Assets DepreciationExpenseOnReclassifiedAssets	100000	usd
CY2021	us-gaap	Payments For Rent PaymentsForRent	400000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23963	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	23963	usd
CY2022	cwbr	Amortization Amortization	-5880	usd
CY2021	cwbr	Amortization Amortization	-4654	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	18083	usd
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	19309	usd
CY2022Q4	us-gaap	Amortization Expense Per Dollar Of Gross Revenue AmortizationExpensePerDollarOfGrossRevenue	1226	usd
CY2021Q4	us-gaap	Amortization Expense Per Dollar Of Gross Revenue AmortizationExpensePerDollarOfGrossRevenue	1125	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	1226	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12000	usd
CY2022Q4	cwbr	Lab Services Supplies LabServicesSupplies	160482	usd
CY2021Q4	cwbr	Lab Services Supplies LabServicesSupplies	6080	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	167386	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	73090	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	112932	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	3918	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	327868	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	196020	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	400000	usd
CY2022	cwbr	Debt Interest Amount DebtInterestAmount	100000	usd
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	500000	usd
CY2022Q3	cwbr	Rent Expense For Space RentExpenseForSpace	13080	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	400000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	133591	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	144077	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	354274	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1800762	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	20980803	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19481137	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1340317	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	252536	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	1419818	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	24228803	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	21678512	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	24228803	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	21678512	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.071	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.07	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.001	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.025	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.109	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.027	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.037	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.001	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.229	pure
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedContractualLifeYears
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1909246	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2723112	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-641044	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-905577	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2550290	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	74800000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	70000000	usd
CY2021Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	1300000	usd
CY2022Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	1300000	usd
CY2022	us-gaap	Net Amount At Risk By Product And Guarantee Guaranteed Minimum Return Rate NetAmountAtRiskByProductAndGuaranteeGuaranteedMinimumReturnRate	0.15	pure
CY2022	us-gaap	Average Term Of Credit Risk Derivatives1 AverageTermOfCreditRiskDerivatives1	P3Y
CY2022	us-gaap	Additional Liability Long Duration Insurance Interest Income Expense AdditionalLiabilityLongDurationInsuranceInterestIncomeExpense	1000000000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.01	pure
CY2022	cwbr	Issuance And Sale Of Stock IssuanceAndSaleOfStock	17000000	shares
CY2022Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	12000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022	cwbr	Amount Of Atm Availability AmountOfATMAvailability	200000	usd
CY2021	cwbr	Amount Of Atm Availability AmountOfATMAvailability	2900000	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	21300	usd
CY2021	cwbr	Issuance And Sale Of Stock IssuanceAndSaleOfStock	700000	shares
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	21.6
CY2022	cwbr	Stock Options Term StockOptionsTerm	P10Y
CY2022	cwbr	Awardee Over A Period AwardeeOverAPeriod	P4Y
CY2022	cwbr	Warrants To Purchase Common Stock Expired And Cancelled WarrantsToPurchaseCommonStockExpiredAndCancelled	67900	shares
CY2021	cwbr	Description Of Granted Stock Options DescriptionOfGrantedStockOptions	the Company granted stock options to employees to purchase 0.2 million shares of the Company’s common stock, including certain time and performance-based inducement awards, with grant date prices that ranged between $10.20 to $41.40 per share. The stock options have terms of ten years and are subject to vesting based on continuous service of the awardee over periods ranging from three to four years. The stock options have an aggregate grant date fair value of $5.8 million.
CY2021	cwbr	Description Of Pursuant Agreement DescriptionOfPursuantAgreement	Pursuant to such agreement, the Company granted Dr. Sarret (1) a time-based inducement nonqualified stock option and (2) a performance-based inducement nonqualified stock option to purchase approximately 0.1 million shares of common stock. The options have an exercise price of $40.50 and the time-based grant will vest as to 25% of the shares on the one-year anniversary of the grant date, May 3, 2021, with the remaining shares subject to the option vesting in 36 equal monthly installments. The time-based inducement award has an aggregate grant date fair value of $2.2 million. As of December 31, 2021, Dr. Sarret satisfied a portion of the performance conditions and 21.6 thousand shares of the 43.3 thousand shares possible under the performance-based award vested. The performance-based award had a fair value of $0.1 million.
CY2022Q4	cwbr	Shares Of Common Stock Purchase SharesOfCommonStockPurchase	21600	shares
CY2021Q4	cwbr	Shares Of Common Stock Purchase SharesOfCommonStockPurchase	51000	shares
CY2022	us-gaap	Other Expenses OtherExpenses	8350	usd
CY2021	us-gaap	Other Expenses OtherExpenses	31687	usd
CY2022	cwbr	Total Noncash Expenses TotalNoncashExpenses	1771508	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	248997	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	179682	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	61.8
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	50.4
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	50.4
CY2021	cwbr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 One SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2One	P6Y3M7D
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Option Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriodGross	210467	usd
CY2021	cwbr	Share Based Compensations Arrangement By Shares Based Payment Award Options Exercisable Granted. ShareBasedCompensationsArrangementBySharesBasedPaymentAwardOptionsExercisableGranted.	42181	usd
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	39.72
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceGranted	40.73
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodWeightedAverageGrantDateFairValue	17.95
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualLifeYears	P6Y3M7D
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	42072	shares
CY2021	cwbr	Stock Options Outstan Share Based Compensation Arrangement By Share Based Payment Award Option Forfeitures And Expirations In Periodding Cancelledin Share StockOptionsOutstanShareBasedCompensationArrangementByShareBasedPaymentAwardOptionForfeituresAndExpirationsInPerioddingCancelledinShare	50981	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	366411	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	204230	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	51.3
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	47.4
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	47.4
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M7D
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Option Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriodGross	19367	usd
CY2022	cwbr	Share Based Compensations Arrangement By Shares Based Payment Award Options Exercisable Granted. ShareBasedCompensationsArrangementBySharesBasedPaymentAwardOptionsExercisableGranted.	694	usd
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.42
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceGranted	10.42
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodWeightedAverageGrantDateFairValue	4.53
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualLifeYears	P6Y3M7D
CY2022	cwbr	Stock Options Outstan Share Based Compensation Arrangement By Share Based Payment Award Option Forfeitures And Expirations In Periodding Cancelledin Share StockOptionsOutstanShareBasedCompensationArrangementByShareBasedPaymentAwardOptionForfeituresAndExpirationsInPerioddingCancelledinShare	67921	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	317857	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	194853	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	45.38
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	38.65
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	38.65
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M7D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	31687	usd
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	317857	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	194853	shares
CY2022Q4	us-gaap	Percentage Of Interest Bearing Domestic Deposits To Deposits Money Market PercentageOfInterestBearingDomesticDepositsToDepositsMoneyMarket	0.85	pure
CY2022Q4	us-gaap	Shares Issued SharesIssued	5600	shares
CY2022	cwbr	Employee Compensation Deferrals EmployeeCompensationDeferrals	25000	usd
CY2022	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	10500	shares
CY2021Q4	us-gaap	Shares Issued SharesIssued	589	shares
CY2021	cwbr	Employee Compensation Deferrals EmployeeCompensationDeferrals	16800	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1663911	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2543712	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	99247	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	140914	usd
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1763158	usd
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	2684626	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8350	usd
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercised		shares
CY2021	cwbr	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercised ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercised
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Exercise ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceExercise
CY2021	cwbr	Total Noncash Expenses TotalNoncashExpenses	2716313	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Revenues Revenues		usd
CY2021	us-gaap	Revenues Revenues		usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2220981	shares
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	cwbr	Costs Of Public Offering CostsOfPublicOffering		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2021	cwbr	Reverse Stock Split Fractional Share Payout ReverseStockSplitFractionalSharePayout		usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations		usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent		usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent		usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercised Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisedDateFairValue
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedContractualLifeYears
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue		usd
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableCancelled		shares
CY2021	cwbr	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelled
CY2021	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceCancelled
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue		usd
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableCancelled		shares
CY2022	cwbr	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelled
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceCancelled
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Cancelled Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelledDateFairValue
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelledd Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelleddContractualLifeYears
CY2022	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001522602

Files In Submission

Name	View Source	Status
0001213900-23-018882-index-headers.html	Edgar Link	pending
0001213900-23-018882-index.html	Edgar Link	pending
0001213900-23-018882.txt	Edgar Link	pending
0001213900-23-018882-xbrl.zip	Edgar Link	pending
cwbr-20221231.xsd	Edgar Link	pending
f10k2022ex23-1_cohbarinc.htm	Edgar Link	pending
f10k2022ex31-1_cohbarinc.htm	Edgar Link	pending
f10k2022ex31-2_cohbarinc.htm	Edgar Link	pending
f10k2022ex32-1_cohbarinc.htm	Edgar Link	pending
f10k2022ex4-1_cohbarinc.htm	Edgar Link	pending
f10k2022_cohbarinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
cwbr-20221231_cal.xml	Edgar Link	unprocessable
cwbr-20221231_def.xml	Edgar Link	unprocessable
cwbr-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cwbr-20221231_pre.xml	Edgar Link	unprocessable
f10k2022_cohbarinc_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBR
CohBar Inc Stock $cwbr

2023 Q1 Form 10-K Financial Statement

#000121390023018882 Filed on March 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBR CohBar Inc Stock $cwbr

2023 Q1 Form 10-K Financial Statement

#000121390023018882 Filed on March 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBR
CohBar Inc Stock $cwbr